Novartis MF59 adjuvanted cell culture-based vaccine shows strong immune response in A(H1N1) clinical trials
Larger pivotal trials with both cell culture and traditional egg based vaccines under way to include more than 6000 adults and children
04-Sep-2009 -
A pilot trial of Novartis adjuvanted cell culture-based A(H1N1) vaccine indicates that the "swine flu" vaccine elicited a strong immune response and was well tolerated. The trial was run by the UK's University of Leicester and University Hospitals of Leicester. The vaccine, to be called Celtura®, ...
antibodies
cell cultures
clinical trials
+4